Articles From: AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease to Should You Count on Social Security?


- Currently no approved treatment options available for patients living with HS, a skin disease which impacts approximately 1 percent of the adult population worldwide1,2 - PIONEER I first Phase 3 trial to evaluate the investigational use of HUMIRA in patients with moderate-to-severe HS3 - Results show HUMIRA meets primary endpoint3 COPENHAGEN, Denmark , Sept.
Sign-up for AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1143880&ProfileId=051205&sourceType=1 HONG KONG, CHINA --
Sign-up for NetDimensions (Holdings) Limited Announces Investor Teach-In investment picks
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT (NYSE:NTT) Group, announced today that car manufacturer Honda Motor Co., Ltd.
Sign-up for NTT Communications' Enterprise Cloud Service Enables Honda to Strengthen Global Supplier Network investment picks
AGOURA HILLS, Calif.
Sign-up for American Homes 4 Rent Announces Pricing of $488 Million Securitization Transaction investment picks
SAN LEANDRO, Calif., Sept.
Sign-up for Energy Recovery Announces Search for New Chief Sales Officer investment picks
HONOLULU , Sept.
Sign-up for Alan Oshima Named President and CEO of Hawaiian Electric Company investment picks
2014/09/04
No single sector in the S&P 500 has raced ahead of the others, but that's not necessarily comforting.
Sign-up for Looking for Froth in S&P 500 Sector Weightings investment picks
2014/09/08
Principal's LifeTime funds make up most of the Morningstar Analyst Ratings changes in August.
Sign-up for A Target-Date Series Diversifies Its Way to a Medal investment picks
2014/09/15
Eight funds with Morningstar Analyst Ratings that have beaten their category averages for at least 10 straight years.
Sign-up for The Longest Winning Streaks Among Our Rated Funds investment picks
2009/08/07
While funds such as CGM Focus and Fairholme have raked in assets, many of their investors are late to the party.
Sign-up for Did You Do as Well as Your Fund? investment picks
2010/04/05
Asset allocation doesn't have to be daunting with this shortcut.
Sign-up for Just Starting Out? Find Your Allocation Baseline investment picks
2012/02/02
Plus, Thornburg loses Growth manager and more.
Sign-up for Huge Facebook IPO, Small Impact on Funds investment picks
2010/04/11
Only funds with the right recipe make it to our most exclusive list.
Sign-up for What Makes a Mutual Fund an Analyst Pick? investment picks
2014/09/03
With the acquisition of MicroEdge, we see plenty of cross-selling and market-expanding opportunities for the combined entity.
Sign-up for Blackbaud Finds a Complementary Edge investment picks
2011/01/27
Investors have lost more than $160 billion in structured and complex income investments, says John Wasik.
Sign-up for Is a Structured Product Good for Retirement Income? investment picks
2011/04/06
Columnist John F.
Sign-up for Response to Structured Products Letter to the Editor investment picks
2014/09/14
There's never a bad time to ensure you have a storm management plan for your portfolio.
Sign-up for Are You Prepared for a Market Correction? investment picks
2014/09/05
With a simple approach to dividend investing, this fund’s performance has earned 4 stars.
Sign-up for A Dividend-Themed Strategic-Beta ETF From WisdomTree investment picks
2014/09/03
The Morningstar Rating shows that the past performance of these funds has been solid.
Sign-up for Strategic-Beta ETFs Seeing Stars investment picks
2011/01/26
Premiums and discounts on your bond ETF aren't as bad as you think.
Sign-up for Bond ETF Pricing: Efficient or Erratic? investment picks
2010/12/08
Product proliferation in the fixed-income space supports portfolio-construction flexibility.
Sign-up for Create Your Own Bond Portfolio Using ETFs investment picks
2014/01/05
Offerings from Oberweis, Rainier, and Seafarer are proving even small funds can be competitive when it comes to picking stocks across the globe.
Sign-up for Frequent Fliers investment picks
2014/08/31
David Iben kept a low profile when he left Nuveen Tradewinds, but now the contrarian is back to running a new global all-cap strategy.
Sign-up for Noted Manager Stays Off the Beaten Path With New Global Fund investment picks
2014/09/12
August proved a lively end to an active summer.
Sign-up for Sector Equity CEFs Excelled in August investment picks
2011/02/02
Don't be caught off guard by taxation of nontraditional ETPs.
Sign-up for Exchange-Traded Products and Taxes investment picks
2014/09/09
Even the strongest have to evolve.
Sign-up for American Funds Adapts to Changing Markets investment picks
2011/01/28
These noteworthy funds show investors the money.
Sign-up for Dividend-Paying Funds That Are Top Picks for Retirees investment picks
2011/04/12
We examine differentiators that help distinguish between two comparable ETFs.
Sign-up for How to Home In on the Best ETFs investment picks
2011/03/22
How well has your fund stacked up to the benchmark during periods of market strength and weakness?
Sign-up for Introducing Upside and Downside Capture Ratios investment picks
2011/04/29
<P>The answers depend on your age.</P>
Sign-up for Should You Count on Social Security? investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: AbbVie Announces Pivotal Phase 3 Data Evaluating Efficacy of HUMIRA® (adalimumab) in Patients with Hidradenitis Suppurativa (HS), a Chronic Inflammatory Skin Disease to Should You Count on Social Security?
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices